Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1905 1
1907 1
1910 1
1911 1
1918 1
1920 1
1921 1
1923 1
1938 1
1950 2
1959 1
1967 1
1972 2
1973 2
1974 3
1975 1
1976 1
1978 2
1979 3
1980 8
1981 4
1982 4
1983 10
1984 7
1985 5
1986 11
1987 8
1988 10
1989 8
1990 10
1991 3
1992 9
1993 4
1994 14
1995 10
1996 14
1997 9
1998 14
1999 12
2000 20
2001 27
2002 15
2003 14
2004 24
2005 18
2006 27
2007 31
2008 26
2009 22
2010 29
2011 39
2012 63
2013 46
2014 57
2015 79
2016 86
2017 56
2018 67
2019 56
2020 36
2021 64
2022 40
2023 53
2024 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,140 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines for the measurement of vascular function and structure in isolated arteries and veins.
Wenceslau CF, McCarthy CG, Earley S, England SK, Filosa JA, Goulopoulou S, Gutterman DD, Isakson BE, Kanagy NL, Martinez-Lemus LA, Sonkusare SK, Thakore P, Trask AJ, Watts SW, Webb RC. Wenceslau CF, et al. Among authors: watts sw. Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H77-H111. doi: 10.1152/ajpheart.01021.2020. Epub 2021 May 14. Am J Physiol Heart Circ Physiol. 2021. PMID: 33989082 Free PMC article. Review.
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. Barnes NM, et al. Among authors: watts sw. Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2).
Fleischmann RM, van der Heijde D, Strand V, Atsumi T, McInnes IB, Takeuchi T, Taylor PC, Bracher M, Brooks D, Davies J, Goode C, Gupta A, Mukherjee S, O'Shea C, Saurigny D, Schifano LA, Shelton C, Smith JE, Wang M, Wang R, Watts S, Weinblatt ME. Fleischmann RM, et al. Among authors: watts s. Ann Rheum Dis. 2023 Dec;82(12):1516-1526. doi: 10.1136/ard-2023-224482. Epub 2023 Sep 12. Ann Rheum Dis. 2023. PMID: 37699654 Free PMC article. Clinical Trial.
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3).
Taylor PC, Weinblatt ME, McInnes IB, Atsumi T, Strand V, Takeuchi T, Bracher M, Brooks D, Davies J, Goode C, Gupta A, Mukherjee S, O'Shea C, Saurigny D, Schifano LA, Shelton C, Smith JE, Wang M, Wang R, Watts S, Fleischmann RM. Taylor PC, et al. Among authors: watts s. Ann Rheum Dis. 2023 Dec;82(12):1527-1537. doi: 10.1136/ard-2023-224449. Epub 2023 Sep 11. Ann Rheum Dis. 2023. PMID: 37696589 Free PMC article. Clinical Trial.
TRAUMATIC CHYLOTHORAX.
Watts SH. Watts SH. Ann Surg. 1921 Dec;74(6):691-6. doi: 10.1097/00000658-192112000-00003. Ann Surg. 1921. PMID: 17864563 Free PMC article. No abstract available.
Chemerin as a Driver of Hypertension: A Consideration.
Ferland DJ, Mullick AE, Watts SW. Ferland DJ, et al. Among authors: watts sw. Am J Hypertens. 2020 Nov 3;33(11):975-986. doi: 10.1093/ajh/hpaa084. Am J Hypertens. 2020. PMID: 32453820 Free PMC article. Review.
Developing digital interventions: a methodological guide.
Bradbury K, Watts S, Arden-Close E, Yardley L, Lewith G. Bradbury K, et al. Among authors: watts s. Evid Based Complement Alternat Med. 2014;2014:561320. doi: 10.1155/2014/561320. Epub 2014 Feb 4. Evid Based Complement Alternat Med. 2014. PMID: 24648848 Free PMC article. Review.
Improving health literacy in patients with diabetes.
Watts SA, Stevenson C, Adams M. Watts SA, et al. Nursing. 2017 Jan;47(1):24-31. doi: 10.1097/01.NURSE.0000510739.60928.a9. Nursing. 2017. PMID: 27922896 Review. No abstract available.
1,140 results